DAA can also strongly activate PPARα, which is mainly involved in the control of lipid metabolism [40], and the fact that PPARα agonists such as Wy-14643 can suppress inflammation in adipose tissues [41] suggests that DAA as a PPARα/γ dual agonist is a valuable medicinal food-derived component for improving the inflammation caused by obesity and for controlling metabolic syndrome. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.